| Literature DB >> 367090 |
Abstract
A therapeutic trial with methenolone (Primobolan) in 19 consecutive patients with different types of refractory anemia is reported. The remission frequencies were: pancytopenia 3/6, bicytopenia 2/4, refractory anemia with hyperplastic marrow 1/5, myelofibrosis 1/4. There was no obvious prolongation of survival in the patients responding. Side-effects were negligible.Entities:
Mesh：
Substances：
Year: 1979 PMID： 367090 DOI： 10.1111/j.0954-6820.1979.tb06010.x
Source DB: PubMed Journal: Acta Med Scand ISSN： 0001-6101